Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Apr 17, 2024 8:17pm
103 Views
Post# 35994999

RE:RE:RE:RE:RE:Maybe, just Maybe the science is basically squat.

RE:RE:RE:RE:RE:Maybe, just Maybe the science is basically squat.Hey big boy

It's a female, but interesting you jumped to that conclusion.

I made my point to illustrate that your ascertations that the science was NFG are really you shooting from the hip, nothing else. Just a naive fear monger.

You will note, if you can read and interpret with any degree of intelligence that I didn't say that implementation success was certain, but that the award of a global, not regional, license agreement with one of the largest biotech, not smallest, on the planet, was a testimony to the scientific platform.

Why don't you offer something real and I will listen.
<< Previous
Bullboard Posts
Next >>